Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:AMAM

Ambrx Biopharma (AMAM) Stock Price, News & Analysis

Ambrx Biopharma logo

About Ambrx Biopharma Stock (NYSE:AMAM)

Advanced Chart

Key Stats

Today's Range
$28.00
$28.00
50-Day Range
$27.70
$28.00
52-Week Range
$6.55
$28.15
Volume
N/A
Average Volume
2.12 million shs
Market Capitalization
$1.77 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AMAM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ambrx Biopharma and its competitors with MarketBeat's FREE daily newsletter.

AMAM Stock News Headlines

The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
14 Day AMERIBOR Average Rate (^AMBRX)
Johnson & Johnson Buys Ambrx Biopharma In $2 Bln Cash Deal
See More Headlines

AMAM Stock Analysis - Frequently Asked Questions

Ambrx Biopharma (AMAM) raised $126 million in an IPO on Friday, June 18th 2021. The company issued 7,000,000 shares at $17.00-$19.00 per share. Goldman Sachs, BofA Securities and Cowen served as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ambrx Biopharma investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), Jabil (JBL), e.l.f. Beauty (ELF), Disc Medicine (IRON) and Adobe (ADBE).

Company Calendar

Today
7/16/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
N/A
Current Symbol
NYSE:AMAM
CIK
1836056
Fax
N/A
Employees
87
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
13.28
Quick Ratio
13.28

Sales & Book Value

Annual Sales
$7.40 million
Price / Sales
238.95
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.05 per share
Price / Book
9.18

Miscellaneous

Outstanding Shares
63,150,000
Free Float
62,746,000
Market Cap
$1.77 billion
Optionable
Optionable
Beta
-1.92
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NYSE:AMAM) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners